Background: The prevalence of kidney stone disease is increasing around the world, notonly in men but in women. All surgical removals of kidney stones, such as extracorporeal shock wave lithotripsy (ESWL) and percutaneous nephrolithotomy (PCNL) have serious side effects and complication. There are parallel undesirable problems in men after conventional treatments of benign prostatic hyperplasia (BPH) with medications and surgery. At the same time Thermobalancing therapy (TT) enabled by Dr Allen's therapeutic device (DATD) has demonstrated positive impact on chronic internal diseases. Therefore, these issues were discussed at the Nephrology Conference in Spain and at the Global Health Conference in China, in October-November 2017.The purpose of this review is to talk about the key points of discussions at these conferences and proposals for the future. Methods and Results: The case study on TT with DATD in patient with kidney stones; and the outcomes from the clinical trial on TT in 124 men with BPH, before and after 6-month period they used DATD. TT with DATD dissolved kidney stones in a woman; reduced Prostate Volume (PV mL) (P<0.001) and diminished urinary symptoms (P<0.001) in men with BPH. Conclusion: The implementations of TT with DATD for the treatment of kidney stone disease were the key note discussions at the Medical Conferences. For over 7 years TT with DATD has been given for hundreds of sufferers with kidney stone disease and thousands with BPH. The results of the case study and clinical trial recommend TT with DATD for kidney stone disease and BPH as the first line treatment. This will help patients to avoid BPH medication and surgical procedures, including ESWL and PCNL, with their risks and complications. Furthermore, DATD should be introduced into the Guidelines for Medical Specialist for men with BPH and people with kidneys stones disease